跳至主要内容
临床试验/NCT07066605
NCT07066605招募中不适用

The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation in Critically Ill Patients"

Sohag University1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2025年6月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
62
试验地点
1
主要终点
Effect of Dexmedetomidine on Agitation During Weaning from Mechanical Ventilation

研究概览

简要总结

This study aims to evaluate the effect of dexmedetomidine on the level of agitation during the weaning process from mechanical ventilation in critically ill patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult ICU patients (≥18 years).
  • •On mechanical ventilation ≥24 hours.
  • •Clinically ready for weaning.
  • •Agitation score RASS ≥ +1 during spontaneous breathing trial.
  • •Intubation for at least 4 days: 2 weeks.

排除标准

  • •Known hypersensitivity to dexmedetomidine.
  • •Hemodynamic instability (HR < 50 bpm or MAP < 60 mmHg).
  • •Neurological impairment affecting level of consciousness.
  • •Pregnancy or lactation.

研究组 & 干预措施

Group A (Dexmedetomidine Group)

Active Comparator

patients will receive dexmedetomidine infusion starting at 0.2 mcg/kg/hr.

干预措施: Group A (Dexmedetomidine Group) (Drug)

Group B (Control Group)

Placebo Comparator

patients will receive standard ICU sedation protocol without dexmedetomidine (e.g., fentanyl)

干预措施: Group B (Control Group) (Drug)

结局指标

主要结局

Effect of Dexmedetomidine on Agitation During Weaning from Mechanical Ventilation

时间窗: every half an hour for two hours

Richmond Agitation-Sedation Scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dalia Ayman Hussien

Resident, Department of Anesthesia, Intensive Care and Pain management, Faculty of Medicine, Sohag University

Sohag University

研究点 (1)

Loading locations...

相似试验